Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results
The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes. Jan 10, 2022
Stryker’s Return to Orthopedics’ Top Spot Years in the Making
Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will reclaim the lead in 2021. Dec 13, 2021
Paragon 28 Completes First Quarter as Public Company
The company grew in the high teens as prior investments in new products and distribution more than offset COVID headwinds. Nov 30, 2021
Medtronic Spine Growth Stymied by COVID Headwinds
The company grew in the low single digits as enabling technology sales and strength in emerging markets helped offset COVID declines. Nov 29, 2021
Vericel Expects Record MACI Sales to End 2021
The company's MACI product declined in the low single digits for 3Q21 but Vericel expects a record-setting fourth quarter. Nov 17, 2021
DJO Outperforms Market Amid COVID Spike
The company grew in the high single digits in 3Q21, led by shoulder implant sales and recent acquisitions. Nov 16, 2021
SI-BONE Achieves Near Universal U.S. Coverage for iFuse
The company grew in the high single digits for 3Q21, driven by an expanding user base and advantageous reimbursement agreements. Nov 16, 2021
Treace Medical Concepts Outperforms Expectations in Third Quarter
The company grew more than +51% in 3Q21, driven by an expanding active surgeon base and increased utlization per surgeon. Nov 15, 2021
Bioventus Acquisition Pays Off in Third Quarter
The company grew nearly +27% in the third quarter of 2021, with nearly half of that growth attributable to recently acquired Bioness. Nov 15, 2021
OrthoPediatrics Grows on Strength of International Sales
The company grew in the double digits for 3Q21, aided by strong international sales in European and South American markets. Nov 12, 2021
